Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of
which has traditionally been deemed as a final stage in AS progression with poor outcomes …

In an ageing population of patients with heart disease, preinterventional frailty assessment
for risk prediction is gaining relevance both in cardiac surgery and transcatheter valve …

Introduction: Over the last decade, transcatheter aortic valve replacement (TAVR) has
emerged as a treatment option for most patients with severe symptomatic aortic stenosis …

Background The usefulness of preprocedural nutritional status to stratify prognosis after
transcatheter aortic valve implantation has been evaluated; however, the studies conducted …

Background Leadless ventricular permanent pacemakers (leadless VVI or LPM) were
designed to reduce lead‐related complications of conventional VVI pacemakers (CPM). The …

Introduction and objectives Carbohydrate antigen 125 (CA125), a biomarker associated with
fluid overload, has proven useful in managing diuretic therapy in heart failure. We aimed to …

Introduction Balloon aortic valvuloplasty (BAV) improves hemodynamic and clinical status of
patients with severe aortic stenosis (AS) for a limited period of 6–12 months. However, there …

Aims After transcatheter aortic valve replacement (TAVR), cardiovascular and non-
cardiovascular comorbidities may offset the survival benefit from the procedure. We aimed to …

Background Owing to the minimally invasive nature of transcatheter aortic valve
replacement (TAVR), TAVR seems to be preferred in patients with cancer; however, related …

Introduction and objectives There are scarce data on the factors associated with impaired
functional status after transcatheter aortic valve replacement (TAVR) and its clinical impact …